Publications 2018

Thème: Autoimmunité, Transplantation, Inflammation ; ATI

1 Aubin F, Courtois J, Puzenat E, Nardin C, Castelain F, Pelletier F, Gastaldi-Ménager C; Société Française de Photodermatologie. Phototherapy in France: quantitative data (2007-2016) from the National Health Insurance Register. J Eur Acad Dermatol Venereol. 2018 Jun;32(6):e224-e225. doi: 10.1111/jdv.14746. PMID: 29224240. IF: 6.898. DERMATOLOGY, Q1.

2 Aubin F, Puzenat E, Pelletier F, Nardin C, Castelain F. Comment on « Trends in phototherapy utilization among Medicare beneficiaries in the United States, 2000 to 2015 ». J Am Acad Dermatol. 2018 Nov 21. pii: S0190-9622(18)32951-7. doi: 10.1016/j.jaad.2018.10.071. PMID: 30471313. IF: 6.898. DERMATOLOGY, Q1.

3 Audia S, Bach B, Samson M, Lakomy D, Bour JB, Burlet B, Guy J, Duvillard L, Branger M, Leguy-Seguin V, Berthier S, Michel M, Bonnotte B. Venous thromboembolic events during warm autoimmune hemolytic anemia. PLoS One. 2018 Nov 8;13(11):e0207218. doi: 10.1371/journal.pone.0207218. PMID: 30408135.IF: 2.766. MULTIDISCIPLINARY SCIENCES, Q

4 Audia S, Moulinet T, Ciudad-Bonté M, Samson M, Facy O, Ortega-Deballon P, Saas P, Bonnotte B. Altered distribution and function of splenic innate lymphoid cells in adult chronic immune thrombocytopenia. J Autoimmun. 2018 Sep;93:139-144. doi: 10.1016/j.jaut.2018.07.015. PMID: 30055825. IF : 7.607. IMMUNOLOGY,Q1.

5 Berthod PE, Aho-Glélé S, Ornetti P, Chevallier O, Devilliers H, Ricolfi F, Bonnotte B, Loffroy R, Samson M. CT analysis of the aorta in giant-cell arteritis: a case-control study. Eur Radiol. 2018 Sep;28(9):3676-3684. doi: 10.1007/s00330-018-5311-8. PMID: 29600479. IF: 4.027. RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING, Q1.

6 Beaussant Y, Daguindau E, Chauchet A, Rochigneux P, Tournigand C, Aubry R, Morin L. Hospital end-of-life care in haematological malignancies. BMJ Support Palliat Care. 2018 Sep;8(3):314-324. doi: 10.1136/bmjspcare-2017-001446. PMID: 29434048. IF: 2.385. HEALTH CARE SCIENCES & SERVICES, Q2.

7 Belizna C, Pregnolato F, Abad S, Alijotas-Reig J, Amital H, Amoura Z, Andreoli L, Andres E, Aouba A, Bilgen SA, Arnaud L, Bienvenu B, Bitsadze V, Blanco P, Blank M, Borghi MO, Caligaro A, Candrea E, Canti V, Chiche L, Chretien JM, Tervaert JWC, Damian L, Delross T, Dernis E, Devreese K, Djokovic A, Esteve-Valverde E, Favaro M, Fassot C, Ferer-Oliveras R, Godon A, Hamidou M, Hasan M, Henrion D, Imbert B, Jeandel PY, Jeannin P, Jego P, Jourde-Chiche N, Khizroeva J, Lambotte O, Landron C, Latino JO, Lazaro E, de Leeuw K, Le Gallou T, Levent K, Liimper M, Loufrani L, Lubin R, Magy-Bertrand N, Mahe G, Makatsariya A, Martin T, Muchardt C, Nagy G, Omarjee L, Van Paasen P, Pernod G, Perrinet F, da Rosa GP, Pistorius MA, Ruffati A, Said F, Saulnier P, Sene D, Sentilhes L, Shovman O, Sibilia J, Sinescu C, Stanisavljevic N, Stojanovitch L, Tam LS, Tincani A, Tollis F, Udry S, Ungeheuer MN, Versini M, Cervera R, Meroni PL. Hibiscus: hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome. Autoimmun Rev. 2018 Dec;17(12):1153-1168. pii: S1568-9972(18)30229-5. doi: 10.1016/j.autrev.2018.05.012. [Epub ahead of print]. PMID: 30316994. IF: 8.745. IMMUNOLOGY, Q1.

8 Bonnefoy F, Gauthier T, Vallion R, Martin-Rodriguez O, Missey A, Daoui A, Valmary-Degano S, Saas P, Couturier M, Perruche S. Factors Produced by Macrophages Eliminating Apoptotic Cells Demonstrate Pro-Resolutive Properties and Terminate Ongoing Inflammation. Front Immunol. 2018 Nov 13;9:2586. doi: 10.3389/fimmu.2018.02586. PMID: 30542342. IF: 5.511. IMMUNOLOGY, Q1.

9 Bouldoires B, Gil H, Soumagne T, Humbert S, Meaux Ruault N, Magy Bertrand N. [A predictive bacterial infection score according to eosinophil level: An observational study]. Rev Med Interne. 2018 Jan;39(1):10-16. doi: 10.1016/j.revmed.2017.10.425. PMID: 29223347. IF: 1.169. MEDICINE, GENERAL & INTERNAL, Q3.

10 Bouiller K, Naudion P, Humbert S, Gil H, Meaux-Ruault N, Cravat M, Revel L, Molimard C, Seronde MF, Magy-Bertrand N. Cardiac Shock Revealing Systemic Lupus Erythematosus. Circ Heart Fail. 2018 Jul;11(7):e005159. doi: 10.1161/CIRCHEARTFAILURE.118.005159. PMID: 29980596. NO IF.

11 Brenière C, Blanc C, Devilliers H, Samson M, Delpont B, Bielefeld P, Besancenot JF, Giroud M, Béjot Y. Associated arterial and venous cerebral manifestations in Behçet’s disease. Rev Neurol (Paris). 2018 May;174(5):337-341. doi: 10.1016/j.neurol.2017.06.031. PMID: 29704959. IF: 1.013 (JCR 1999). CLINICAL NEUROLOGY, Q3.

12 Castelain F, Girardin P, Penven E, Pelletier F. Occupational contact dermatitis caused by polyurethane foam: 6 cases. Contact Dermatitis. 2018 Jul;79(1):52-54. doi: 10.1111/cod.12989. [Epub ahead of print]. PMID: 29635841. IF: 4.275. ALLERGY, Q2. DERMATOLOGY, Q1.

13 Choux C, Cavalieri M, Barberet J, Samson M, Bonnotte B, Fauque P, Sagot P. [Immunosuppressive therapy and fertility preservation: Indications and methods]. Rev Med Interne. 2018 Jul;39(7):557-565. doi: 10.1016/j.revmed.2018.02.010. PMID: 29500075. IF: 1.169. MEDICINE, GENERAL & INTERNAL, Q3.

14 Charles P, Terrier B, Perrodeau É, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group. Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2). Ann Rheum Dis. 2018 Aug;77(8):1143-1149. doi: 10.1136/annrheumdis-2017-212878. PMID: 29695500. IF: 12.350. RHEUMATOLOGY, Q1.

15 Collignon A, Silvy F, Robert S, Trad M, Germain S, Nigri J, André F, Rigot V, Tomasini R, Bonnotte B, Lombardo D, Mas E, Beraud E. Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma. Oncoimmunology. 2018 Sep 25;7(12):e1504727. doi: 10.1080/2162402X.2018.1504727. eCollection 2018. PMID: 30524902. IF: 5.503. ONCOLOGY, Q1. IMMUNOLOGY, Q1.

16 Coutier F, Meaux Ruault N, Crepin T, Bouiller K, Gil H, Humbert S, Bedgedjian I, Magy-Bertrand N. A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review. Ann Hematol. 2018 Mar;97(3):401-407. doi: 10.1007/s00277-017-3138-z. PMID: 28956126. IF: 2.845. HEMATOLOGY, Q2.

17 Courivaud C. [Incremental haemodialysis]. Nephrol Ther. 2018 Apr;14 Suppl 1:S89-S92. doi: 10.1016/j.nephro.2018.02.016. PMID: 29606268. IF: 0.479. UROLOGY & NEPHROLOGY, Q4.

18 de Boysson H, Daumas A, Vautier M, Parienti JJ, Liozon E, Lambert M, Samson M, Ebbo M, Dumont A, Sultan A, Bonnotte B, Manrique A, Bienvenu B, Saadoun D, Aouba A. Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients. Autoimmun Rev. 2018 Apr;17(4):391-398. doi: 10.1016/j.autrev.2017.11.029. Epub 2018 Feb 7. PMID: 29427822. IF: 8.745. IMMUNOLGOY, Q1.

19 Deshayes S, Georgin-Lavialle S, Hot A, Durel CA, Hachulla E, Rouanes N, Audia S, Le Gallou T, Quartier P, Urbanski G, Messer L, Klein S, de Boysson H, Bienvenu B, Grateau G, Aouba A. Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase Deficiency: A Multicenter Retrospective Study in 13 Adult Patients and Literature Review. J Rheumatol. 2018 Mar;45(3):425-429. doi: 10.3899/jrheum.170684. PMID: 29335349. IF: 3.470. RHEUMATOLOGY, Q2.

20 Ducloux D, Bamoulid J, Daguindau E, Rebibou JM, Courivaud C, Saas P. Antithymocytes globulins: Time to revisit its use in kidney transplantation? Int Rev Immunol. 2018 Aug 6:1-9. doi: 10.1080/08830185.2018.1455194. [Epub ahead of print]. PMID: 30081695. IF: 2.933. IMMUNOLOGY, Q3.

21 Ducloux D, Legendre M, Bamoulid J, Rebibou JM, Saas P, Courivaud C, Crepin T. ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications. Immun Ageing. 2018;37(4):183-191. doi: 10.1186/s12979-018-0121-z. PMID: 30026783. PFB. IF: 4.019. GERIATRICS & GERONTOLOGY, Q1. IMMUNOLOGY, Q2.

22 Gallian P, Barlet V, Mouna L, Gross S, Lecam S, Ricard C, Wind F, Pouchol E, Fabra C, Flan B, Visse C, Djoudi R, Couturier E, de Valk H, Tiberghien P, Roque-Afonso AM. Hepatitis A: an epidemiological survey in blood donors, France 2015 to 2017. Euro Surveill. 2018 May;23(21). doi: 10.2807/1560-7917.ES.2018.23.21.1800237. PMID: 29845926. NO IF.

23 Galland J, Abbara S, Terrier B, Samson M, Tesnières A, Fournier JP, Braun M. [Simulation-based learning and internal medicine: Opportunities and current perspectives for a national harmonized program]. Rev Med Interne. 2018 Jun;39(6):414-420. doi: 10.1016/j.revmed.2017.11.011. PMID: 29548580. IF: 1.169. MEDICINE, GENERAL & INTERNAL, Q3.

24 Garban F, Guyard A, Labussière H, Bulabois CE, Marchand T, Mounier C, Caillot D, Bay JO, Coiteux V, Schmidt-Tanguy A, Le Niger C, Robin C, Ladaique P, Lapusan S, Deconinck E, Rolland C, Foote AM, François A, Jacquot C, Tardivel R, Tiberghien P, Bosson JL; Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process (EFFIPAP) Study Group. Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial. JAMA Oncol. 2018 Apr 1;4(4):468-475. doi: 10.1001/jamaoncol.2017.5123. PMID: 29392283. IF: 20.871. ONCOLOGY, Q1.

25 Girerd S, Frimat L, Ducloux D, Le Meur Y, Mariat C, Moulin B, Mousson C, Rieu P, Dali-Youcef N, Merckle L, Lepage X, Rossignol P, Girerd N, Jaisser F. EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial. Trials. 2018 Oct 30;19(1):595. doi: 10.1186/s13063-018-2956-1. PMID: 30376884. IF: 2.067. MEDICINE RESEARCH & EXPERIMENTAL, Q.

26 Guillon B, Ecarnot F, Marcucci C, Ducloux D, Chatot M, Badoz M, Bonnet B, Chopard R, Frey P, Meneveau N, Schiele F. Incidence, Predictors, and Impact on Six-Month Mortality of Three Different Definitions of Contrast-Induced Acute Kidney Injury After Coronary Angiography. Am J Cardiol. 2018 Apr 1;121(7):818-824. doi: 10.1016/j.amjcard.2017.12.029. PMID: 29397881. IF: 3.171. CARDIAC & CARDIOVASCULAR SYSTEMS, Q2.

27 Guitton Z, Terriou L, Lega JC, Nove-Josserand R, Hie M, Amoura Z, Bussel JB, Hamidou M, Rosenthal E, Lioger B, Chauveau D, Chaminade A, Magy-Bertrand N, Michel M, Audia S, Godeau B, Mahevas M. Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists. Rheumatology (Oxford). 2018 Aug 1;57(8):1432-1438. doi: 10.1093/rheumatology/key119. PMID: 29757439. IF: 5.245. RHEUMATOLOGY, Q1.

28 Hadjadj J, Canaud G, Mirault T, Samson M, Bruneval P, Régent A, Goulvestre C, Witko-Sarsat V, Costedoat-Chalumeau N, Guillevin L, Mouthon L, Terrier B; French Vasculitis Study Group. mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G. Rheumatology (Oxford). 2018 Jun 1;57(6):1011-1020. doi: 10.1093/rheumatology/key017. PMID: 29506143. IF: 5.245. RHEUMATOLOGY, Q1.

29 Humbert P, Louvrier L. Photoexposed skin, skin aging, bateman purpura and local vitamin c deficiency. J Eur Acad Dermatol Venereol. 2018 Oct;32(10):e383-e384. doi: 10.1111/jdv.14980. PMID: 29633407. IF: 6.898. DERMATOLOGY, Q1.

30 Jacquin-Porretaz C, Castelain F, Daguindau E, Seilles E, Nardin C, Aubin F, Pelletier F. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases]. Ann Dermatol Venereol. 2018 Oct;145(10):598-602. doi: 10.1016/j.annder.2018.02.012. PMID: 29673745. IF: 1.051. DERMATOLOGY, Q4.

31 Louvrier A, Euvrard E, Nicod L, Rolin G, Gindraux F, Pazart L, Houdayer C, Risold PY, Meyer F, Meyer C. Odontoblastic differentiation of dental pulp stem cells from healthy and carious teeth on an original PCL-based 3D scaffold. Int Endod J. 2018 May;51 Suppl 4:e252-e263. doi: 10.1111/iej.12746. Epub 2017 Feb 23. PMID: 28109162. IF: 3.015. DENTISTRY, ORAL SURGERY & MEDICINE, Q1.

32 Mouloungui E, Zver T, Roux C, Amiot C. A protocol to isolate and qualify purified human preantral follicles in cases of acute leukemia, for future clinical applications. J Ovarian Res. 2018 Jan 5;11(1):4. doi: 10.1186/s13048-017-0376-6. PMID: 29304838. IF: 2.367. REPRODUCTIVE BIOLOGY, Q3.

33 Nardin C, Colas M, Curie V, Pelletier F, Puzenat E, Aubin F. Pregnancy After Tubal Sterilization in a Woman Treated with Biologics for Severe Psoriasis. Dermatol Ther (Heidelb). 2018 Jun;8(2):323-326. doi: 10.1007/s13555-018-0232-7. PMID: 29524191. IF: 1.550. DERMATOLOGY, Q3.

34 Nakyai W, Tissot M, Humbert P, Grandmottet F, Viyoch J, Viennet C. Effects of Repeated UVA Irradiation on Human Skin Fibroblasts Embedded in 3D Tense Collagen Matrix. Photochem Photobiol. 2018 Jul;94(4):715-724. doi: 10.1111/php.12895. PMID: 29421845. IF: 2.214. BIOCHEMISTRY & MOLECULAR BIOLOGY, Q3. BIOPHYSICS, Q3.

35 Pastissier A, Humbert S, Naudion P, Meaux-Ruault N, Badoz M, Magy-Bertrand N. Severe Sinus Bradycardia in Puumala virus infection. Int J Infect Dis. 2018 Nov 29;79:75-76. doi: 10.1016/j.ijid.2018.11.019. PMID: 30503652. IF: 3.202. INFECTIOUS DISEASES, Q

36 Pugliesi PS, Guenancia C, Cottin Y, Rebibou JM. Could vagal tone increase explain the excess of bradycardia episodes during the last day of the long interdialytic interval? Kidney Int. 2018 Aug;94(2):430. doi: 10.1016/j.kint.2018.05.011. PMID: 30031448. IF = 8.429. UROLOGY & NEPHROLOGY, Q1.

37 Rahrovan S, Fanian F, Mehryan P, Humbert P, Firooz A. Male versus female skin: What dermatologists and cosmeticians should know. Int J Womens Dermatol. 2018 Jun 22;4(3):122-130. doi: 10.1016/j.ijwd.2018.03.002. PMID: 30175213. NO IF.

38 Ravanat C, Dupuis A, Marpaux N, Naegelen C, Mourey G, Isola H, Laforêt M, Morel P, Gachet C. In vitro quality of amotosalen-UVA pathogen-inactivated mini-pool plasma prepared from whole blood stored overnight. Vox Sang. 2018 Oct;113(7):622-631. doi: 10.1111/vox.12697. PMID: 30079963. IF: 2.107. HEMATOLOGY, Q.

39 Roche H, Bouiller K, Puzenat E, Deveza E, Roche B, Pelletier F, van de Laak A, Dupond AS, Nardin C, Aubin F. Efficacy and Survival of Biologic Agents in psoriasis: A practical real-life 12-year experience in a French dermatology department. J Dermatolog Treat. 2018 May 31:1-17. doi: 10.1080/09546634.2018.1480746. [Epub ahead of print]. PMID: 29848153. IF: 2.044. DERMATOLOGY, Q2.

40 Rubio MT, Galaine J, Borg C, Daguindau É. Biologie, concepts et principes des CAR-T cells. Bull Cancer. 2018 Dec;105 Suppl 2:S135-S146. doi: 10.1016/S0007-4551(19)30044-X. PMID: 30686352. IF: 0.84. Oncology, Q4.

41 Samson M, Bonnotte B. [Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?]. Rev Med Interne. 2018 Feb;39(2):75-77. doi: 10.1016/j.revmed.2017.11.003. PMID: 29217104. IF: 1.169. MEDICINE, GENERAL & INTERNAL, Q3.

42 Samson M, Devilliers H, Ly KH, Maurier F, Bienvenu B, Terrier B, Charles P, Guillevin L, Besancenot JF, Liozon E, Fauchais AL, Loffroy R, Binquet C, Audia S, Seror R, Mariette X, Bonnotte B. Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study. Eur J Intern Med. 2018 Nov;57:96-104. doi: 10.1016/j.ejim.2018.06.008. PMID: 30054122. IF: 3.282. MEDICINE, GENERAL & AND INTERNAL, Q1.

43 Samson M, Espígol-Frigolé G, Terrades-García N, Prieto-González S, Corbera-Bellalta M, Alba-Rovira R, Hernández-Rodríguez J, Audia S, Bonnotte B, Cid MC. Biological treatments in giant cell arteritis & Takayasu arteritis. Eur J Intern Med. 2018 Apr;50:12-19. doi: 10.1016/j.ejim.2017.11.003. PMID: 29146018. IF: 3.282. MEDICINE, GENERAL & AND INTERNAL, Q1.

44 Samson M, Ghesquière T, Berthier S, Bonnotte B. Ustekinumab inhibits Th1 and Th17 polarisation in a patient with giant cell arteritis. Ann Rheum Dis. 2018 Feb;77(2):e6. doi: 10.1136/annrheumdis-2017-211622. PMID: 28501800. IF: 12.350. RHEUMATOLOGY, Q1.

45 Serratrice C, Bensalah N, Penaranda G, Bardin N, Belmatoug N, Masseau A, Rose C, Lidove O, Camou F, Maillot F, Leguy V, Magy-Bertrand N, Marie I, Cherin P, Bengherbia M, Carballo S, Boucraut J, Serratrice J, Berger M, Verrot D. Prevalence of autoantibodies in the course of Gaucher disease type 1: A multicenter study comparing Gaucher disease patients to healthy subjects. Joint Bone Spine. 2018 Jan;85(1):71-77. doi: 10.1016/j.jbspin.2016.12.002. PMID: 28034821. IF = 3.304. RHEUMATOLOGY, Q2.

46 Sevin M, Kubovcakova L, Pernet N, Causse S, Vitte F, Villeval JL, Lacout C, Cordonnier M, Rodrigues-Lima F, Chanteloup G, Mosca M, Chrétien ML, Bastie JN, Audia S, Sagot P, Ramla S, Martin L, Gleave M, Mezger V, Skoda R, Plo I, Garrido C, Girodon F, de Thonel A. HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis. Nat Commun. 2018 Apr 12;9(1):1431. doi: 10.1038/s41467-018-03627-9. PMID: 29650953. IF : 12.353. MULTIDISCIPLINARY SCIENCES, Q1.

47 Surber C, Humbert P, Abels C, Maibach H. The Acid Mantle: A Myth or an Essential Part of Skin Health? Curr Probl Dermatol. 2018;54:1-10. doi: 10.1159/000489512. PMID: 30125885. NO IF.

48 Terrier B, Pagnoux C, Perrodeau É, Karras A, Khouatra C, Aumaître O, Cohen P, Decaux O, Desmurs-Clavel H, Maurier F, Gobert P, Quémeneur T, Blanchard-Delaunay C, Bonnotte B, Carron PL, Daugas E, Ducret M, Godmer P, Hamidou M, Lidove O, Limal N, Puéchal X, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group. Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides. Ann Rheum Dis. 2018 Aug;77(8):1150-1156. doi: 10.1136/annrheumdis-2017-212768. PMID: 2972472. IF: 12.350. RHEUMATOLOGY, Q1.

49 Toussirot E, Béreau M, Vauchy C, Saas P. Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical Evidence. Front Physiol. 2018 Apr 24;9:440. doi: 10.3389/fphys.2018.00440. PMID: 29740348. IF: 3.394. PHYSIOLOGY, Q1.

50 Toussirot É, Laheurte C, Gaugler B, Gabriel D, Saas P. Increased IL-22- and IL-17A-Producing Mucosal-Associated Invariant T Cells in the Peripheral Blood of Patients With Ankylosing Spondylitis. Front Immunol. 2018 Jul 13;9:1610. doi: 10.3389/fimmu.2018.01610. PMID: 30057583. PFB. IF: 5.511. IMMUNOLOGY, Q1.

51 Toussirot E, Saas P. MAIT cells: potent major cellular players in the IL-17 pathway of spondyloarthritis? RMD Open. 2018 Dec 28;4(2):e000821. PMID: 30687517. No IF.

52 Wang Y, Tissot M, Rolin G, Muret P, Robin S, Berthon JY, He L, Humbert P, Viennet C. Development and validation of a simple method for the extraction of human skin melanocytes. Cytotechnology. 2018 Aug;70(4):1167-1176. doi: 10.1007/s10616-018-0207-7. [Epub ahead of print]. PMID: 29564589. IF: 1.461. BIOTECHNOLOGY AND APPLIED MICROBIOLOGY, Q3. CELL BIOLOGY, Q4.

53 Wang Y, Viennet C, Jeudy A, Fanian F, He L, Humbert P. Assessment of the efficacy of a new complex antisensitive skin cream. J Cosmet Dermatol. 2018 Dec;17(6):1101-1107. doi: 10.1111/jocd.12486. [Epub ahead of print]. PMID: 29356277. IF: 1.529. DERMATOLOGY, Q3.

Thème: Thérapeutique ImmunoMoléculaire des Cancers ; TIM-C

1 Aarnink A, Richard C, Truntzer C, Vincent J, Bengrine L, Vienot A, Borg C, Ghiringhelli F. Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma. Oncotarget. 2018 May 22;9(39):25617-25629. doi: 10.18632/oncotarget.25424. eCollection 2018 May 22. PMID: 29876012. IF: suspendu.

2 Adotevi O, Godet Y, Galaine J, Lakkis Z, Idirene I, Certoux JM, Jary M, Loyon R, Laheurte C, Kim S, Dormoy A, Pouthier F, Barisien C, Fein F, Tiberghien P, Pivot X, Valmary-Degano S, Ferrand C, Morel P, Delabrousse E, Borg C. In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial. Oncoimmunology. 2018 Mar 19;7(5):e1424673. PMID: 29721386. PFB. IF: 5.503. ONCOLOGY, Q1. IMMUNOLOGY, Q1.

3 André T, Vernerey D, Mineur L, Bennouna J, Desrame J, Faroux R, Fratte S, Hug de Larauze M, Paget-Bailly S, Chibaudel B, Bez J, Dauba J, Louvet C, Lepere C, Dupuis O, Becouarn Y, Mabro M, Egreteau J, Bouche O, Deplanque G, Ychou M, Galais MP, Ghiringhelli F, Dourthe LM, Bachet JB, Khalil A, Bonnetain F, de Gramont A, Taieb J; for PRODIGE investigators, GERCOR, Fédération Française de Cancérologie Digestive, and UNICANCER. 3 Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial. J Clin Oncol. 2018 Apr 5:JCO2017760355. doi: 10.1200/JCO.2017.76.0355. [Epub ahead of print]. PMID: 29620995. IF: 26.303. ONCOLOGY, Q1.

4 Asgarova A, Asgarov K, Godet Y, Peixoto P, Nadaradjane A, Boyer-Guittaut M, Galaine J, Guenat D, Mougey V, Perrard J, Pallandre JR, Bouard A, Balland J, Tirole C, Adotevi O, Hendrick E, Herfs M, Cartron PF, Borg C, Hervouet E. PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma. Oncoimmunology. 2018 Feb 1;7(5):e1423170. doi: 10.1080/2162402X.2017.1423170. PMID: 29721376. IF: 5.503. ONCOLOGY, Q1. IMMUNOLOGY, Q1.

5 Auclin E, André T, Taieb J, Benetkiewicz M, de Gramont A, Vernerey D. Low-level postoperative carcinoembryonic antigen improves survival outcomes stratification in patients with stage II colon cancer treated with standard adjuvant treatments. Eur J Cancer. 2018 Jul;97:55-56. doi: 10.1016/j.ejca.2018.03.032. PMID: 29731226. IF: 7.191. ONCOLOGY, Q1.

6 Bachet JB, Bouché O, Taieb J, Dubreuil O, Garcia ML, Meurisse A, Normand C, Gornet JM, Artru P, Louafi S, Bonnetain F, Thirot-Bidault A, Baumgaertner I, Coriat R, Tougeron D, Lecomte T, Mary F, Aparicio T, Marthey L, Taly V, Blons H, Vernerey D, Laurent-Puig P. RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study. Ann Oncol. 2018 May 1;29(5):1211-1219. doi: 10.1093/annonc/mdy061. PMID: 29438522. IF: 13.926. ONCOLOGY, Q1.

7 Baraquin A, Hervouet E, Richou C, Flori P, Peixoto P, Azizi A, Delabrousse E, Blagosklonov O, Umhang G, Bresson-Hadni S, Valot B, Grenouillet F; EchinoVista study group. Circulating cell-free DNA in patients with alveolar echinococcosis. Mol Biochem Parasitol. 2018 Apr 18;222:14-20. doi: 10.1016/j.molbiopara.2018.04.004. PMID: 29679605. IF: 1.744. BIOCHEMISTRY & MOLECULAR BIOLOGY, Q4. PARASITOLOGY, Q3.

8 Bascoul-Mollevi C, Savina M, Anota A, Barbieri A, Azria D, Bonnetain F, Gourgou S. Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD. Comput Methods Programs Biomed. 2018 May;158:153-159. doi: 10.1016/j.cmpb.2018.02.010. Epub 2018 Feb 17. PMID: 29544781. IF: 2.674. COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS, Q2. COMPUTER SCIENCE, THEORY & METHODS, Q1. ENGINEERING, BIOMEDICAL, Q2. MEDICAL INFORMATICS, Q2.

9 Baudry AS, Anota A, Bonnetain F, Mariette C, Christophe V. Psychometric validation of the French version of the Supportive Care Needs Survey for Partners and Caregivers of cancer patients. Eur J Cancer Care (Engl). 2018 Aug 31:e12896. doi: 10.1111/ecc.12896. PMID: 30168874. IF: 2.409. ONCOLOGY, Q3. HEALTHCARE SCIENCES & SERVICES, Q2. NURSING, Q1. REHABILITATION, Q1.

10 Bellanger AP, Berceanu A, Rocchi S, Valot B, Fontan J, Chauchet A, Belin N, Scherer E, Deconinck E, Navellou JC, Millon L. Development of a quantitative PCR detecting Cunninghamella bertholletiae to help in diagnosing this rare and aggressive mucormycosis. Bone Marrow Transplant. 2018 Sep;53(9):1180-1183. doi: 10.1038/s41409-018-0194-5. PMID: 29712993. IF: 4.497. ONCOLOGY, Q2. HEMATOLOGY, Q1. IMMUNOLOGY, Q2. TRANSPLANTATION, Q1.

11 Beziaud L, Boullerot L, Tran T, Mansi L, Marie-Joseph EL, Ravel P, Johannes L, Bayry J, Tartour E, Adotévi O. Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy. Int J Cancer. 2018 Dec 1;143(11):3008-3018. doi: 10.1002/ijc.31842. [Epub ahead of print]. PMID: 30183073. IF: 7.360. ONCOLOGY, Q1.

12 Brédart A, Anota A, Dick J, Kuboth V, Lareyre O, De Pauw A, Cano A, Stoppa-Lyonnet D, Schmutzler R, Dolbeault S, Kop JL. Patient-Centered Care in Breast Cancer Genetic Clinics. Int J Environ Res Public Health. 2018 Feb 12;15(2). pii: E319. doi: 10.3390/ijerph15020319. PMID: 29439543. IF: 1.019. ENVIRONMENTAL SCIENCES, Q4.

13 Brédart A, Anota A, Young T, Tomaszewski KA, Arraras JI, Moura De Albuquerque Melo H, Schmidt H, Friend E, Bergenmar M, Costantini A, Vassiliou V, Hureaux J, Marchal F, Tomaszewska IM, Chie WC, Ramage J, Beaudeau A, Conroy T, Bleiker E, Kulis D, Bonnetain F, Aaronson NK; EORTC Quality of Life Group. Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT-C33) and specific complementary outpatient module (EORTC OUT-PATSAT7). Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12786. Epub 2017 Nov 2. PMID: 29094784. IF: 2.409. ONCOLOGY, Q3. HEALTHCARE SCIENCES & SERVICES, Q2. NURSING, Q1. REHABILITATION, Q1.

14 Cadranel J, Cortot AB, Lena H, Mennecier B, Do P, Dansin E, Mazieres J, Chouaid C, Perol M, Barlesi F, Robinet G, Friard S, Thiberville L, Audigier-Valette C, Vergnenegre A, Westeel V, Slimane K, Buturuga A, Moro-Sibilot D, Besse B. Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients. ERJ Open Res. 2018 Feb 13;4(1). pii: 00058-2017. doi: 10.1183/23120541.00058-2017. eCollection 2018 Jan. PMID: 29450203. NO IF.

15 Carola C, Ghiringhelli F, Kim S, André T, Barlet J, Bengrine-Lefevre L, Marijon H, Garcia-Larnicol ML, Borg C, Dainese L, Steuer N, Richa H, Benetkiewicz M, Larsen AK, de Gramont A, Chibaudel B. FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer. World J Clin Oncol. 2018 Sep 14;9(5):110-118. doi: 10.5306/wjco.v9.i5.110. PMID: 30254966. NO IF.

16 Cesaro S, Tridello G, Blijlevens N, Ljungman P, Craddock C, Michallet M, Martin A, Snowden JA, Mohty M, Maertens J, Passweg J, Petersen E, Nihtinen A, Isaksson C, Milpied N, Rohlich PS, Deconinck E, Crawley C, Ledoux MP, Hoek J, Nagler A, Styczynski J. Incidence, Risk Factors and Long-Term Outcome of Acute Leukemia Patients with Early Candidemia after Allogeneic Stem Cell Transplantation. A Study by the Acute Leukemia and Infectious Diseases Working Parties of EBMT. Clin Infect Dis. 2018 Aug 1;67(4):564-572. doi: 10.1093/cid/ciy150. PMID: 29481599. IF: 9.117. IMMUNOLOGY, Q1. INFECTIOUS DISEASES, Q1. MICROBIOLOGY, Q1.

17 Chaigneau L, Patrikidou A, Ray-Coquard I, Valentin T, Linassier C, Bay JO, Moureau Zabotto L, Bompas E, Piperno-Neumann S, Penel N, Alcindor T, Laigre M, Guillemet C, Salas S, Hugli A, Domont J, Sunyach MP, Lecesne A, Blay JY, Nerich V, Isambert N. Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO). Oncologist. 2018 Aug;23(8):948-955. doi: 10.1634/theoncologist.2017-0136. Epub 2018 Jun 22. PMID: 29934413. IF: 5.306. ONVOLOGY, Q1.

18 Claude-Taupin A, Fonderflick L, Gauthier T, Mansi L, Pallandre JR, Borg C, Perez V, Monnien F, Algros MP, Vigneron M, Adami P, Delage-Mourroux R, Peixoto P, Herfs M, Boyer-Guittaut M, Hervouet E. ATG9A Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer Phenotypes. Cells. 2018 Dec 6;7(12). pii: E248. doi: 10.3390/cells7120248. PMID: 30563263. IF: 4.829, CELL BIOLOGY, Q1.

19 Craddock C, Versluis J, Labopin M, Socie G, Huynh A, Deconinck E, Volin L, Milpied N, Bourhis JH, Rambaldi A, Chevallier P, Blaise D, Manz M, Vellenga E, Vekemans MC, Maertens J, Passweg J, Vyas P, Schmid C, Löwenberg B, Ossenkoppele G, Mohty M, Cornelissen JJ, Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and HOVON-SAKK. Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia. J Intern Med. 2018 Apr;283(4):371-379. doi: 10.1111/joim.12720. PMID: 29214689. IF: 6.754. MEDICINE, GENERAL & INTERNAL, Q1.

20 Decroocq J, Itzykson R, Vigouroux S, Michallet M, Yakoub-Agha I, Huynh A, Beckerich F, Suarez F, Chevallier P, Nguyen-Quoc S, Ledoux MP, Clement L, Hicheri Y, Guillerm G, Cornillon J, Contentin N, Carre M, Maillard N, Mercier M, Mohty M, Beguin Y, Bourhis JH, Charbonnier A, Dauriac C, Bay JO, Blaise D, Deconinck E, Jubert C, Raus N, Peffault de Latour R, Dhedin N. Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Am J Hematol. 2018 Mar;93(3):416-423. doi: 10.1002/ajh.25004. PMID: 29226497. IF: 5.303. HEMATOLOGY, Q1.

21 Deliu N, Cottone F, Collins GS, Anota A, Efficace F. Evaluating methodological quality of Prognostic models Including Patient-reported HeAlth outcomes iN oncologY (EPIPHANY): a systematic review protocol. BMJ Open. 2018 Oct 24;8(10):e025054. doi: 10.1136/bmjopen-2018-025054. PMID: 30361409.

22 Dosset M, Vargas TR, Lagrange A, Boidot R, Végran F, Roussey A, Chalmin F, Dondaine L, Paul C, Marie-Joseph EL, Martin F, Ryffel B, Borg C, Adotévi O, Ghiringhelli F, Apetoh L. PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer. Oncoimmunology. 2018 Mar 15;7(6):e1433981. doi: 10.1080/2162402X.2018.1433981. eCollection 2018. PMID: 29872568. IF: 5.503. ONCOLOGY, Q1. IMMUNOLOGY, Q1.

23 Efficace F, Cottone F, Abel G, Niscola P, Gaidano G, Bonnetain F, Anota A, Caocci G, Cronin A, Fianchi L, Breccia M, Stauder R, Platzbecker U, Palumbo GA, Luppi M, Invernizzi R, Bergamaschi M, Borin L, Di Tucci AA, Zhang H, Sprangers M, Vignetti M, Mandelli F. Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes. Cancer. 2018 Mar 15;124(6):1251-1259. doi: 10.1002/cncr.31193. Epub 2017 Dec 12. PMID: 29231969. IF: 6.537. ONCOLOGY, Q1.

24 Ferrara R, Mezquita L, Texier M, Lahmar J, Audigier-Valette C, Tessonnier L, Mazieres J, Zalcman G, Brosseau S, Le Moulec S, Leroy L, Duchemann B, Lefebvre C, Veillon R, Westeel V, Koscielny S, Champiat S, Ferté C, Planchard D, Remon J, Boucher ME, Gazzah A, Adam J, Bria E, Tortora G, Soria JC, Besse B, Caramella C. Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy. JAMA Oncol. 2018 Sep 6. doi: 10.1001/jamaoncol.2018.3676. [Epub ahead of print]. PMID: 30193240. IF: 20.871. ONCOLOGY, Q1.

25 Ferrer L, Giaj Levra M, Brevet M, Antoine M, Mazieres J, Rossi G, Chiari R, Westeel V, Poudenx M, Letreut J, Gervais R, Osman G, Girard N, Toffart AC, Novello S, Moro-Sibilot D. A brief report of transformation from Non-small cell to small cell lung cancer: Molecular and therapeutic characteristics. J Thorac Oncol. 2018 Sep 11. pii: S1556-0864(18)33044-2. doi: 10.1016/j.jtho.2018.08.2028. [Epub ahead of print]. PMID: 30217489. IF: 10.340.ONCOLOGY, Q1.

26 Fiteni F, Paillard MJ, Orillard E, Lefebvre L, Nadjafizadeh S, Selmani Z, Benhamida S, Roland A, Baumann A, Vienot A, Houédé N, Pivot X. Enterocolitis in Patients with Cancer Treated with Docetaxel. Anticancer Res. 2018 Apr;38(4):2443-2446. PMID: 29599375. IF: 1.865. ONCOLOGY, Q4.

27 Fogelman D, Cubillo A, García-Alfonso P, Mirón MLL, Nemunaitis J, Flora D, Borg C, Mineur L, Vieitez JM, Cohn A, Saylors G, Assad A, Switzky J, Zhou L, Bendell J. Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer. Cancer Med. 2018 Nov;7(11):5382-5393. doi: 10.1002/cam4.1703. [Epub ahead of print]. PMID: 30123970. IF: 3.202. ONCOLOGY, Q2.

28 Gamper EM, Holzner B, King MT, Norman R, Viney R, Nerich V, Kemmler G. Test-Retest Reliability of Discrete Choice Experiment for Valuations of QLU-C10D Health States. Value Health. 2018 Aug;21(8):958-966. doi: 10.1016/j.jval.2017.11.012. Epub 2018 Mar 3. PMID: 30098674. IF: 5.494. HEALHT CARE SCIENCES, Q1.

29 Gillet N, Fouquereau E, Coillot H, Bonnetain F, Dupont S, Moret L, Anota A, Colombat P. Ethical leadership, professional caregivers’ well-being, and patients’ perceptions of quality of care in oncology. Eur J Oncol Nurs. 2018 Apr;33:1-7. doi: 10.1016/j.ejon.2018.01.002. Epub 2018 Jan 12. PMID: 29551170. IF: 1.812. ONCOLOGY, Q4. NURSING, Q1.

30 Gilleece MH, Labopin M, Yakoub-Agha I, Volin L, Socié G, Ljungman P, Huynh A, Deconinck E, Wu D, Bourhis JH, Cahn JY, Polge E, Mohty M, Savani BN, Nagler A. Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation. Am J Hematol. 2018 Sep;93(9):1142-1152. doi: 10.1002/ajh.25211. PMID: 29981272. IF: 5.303. HEMATOLOGY, Q1.

31 Gligorov J, Richard S, Pivot X. Emilia: use cunning to survive cancer. Chin Clin Oncol. 2018 Feb;7(1):5. doi: 10.21037/cco.2017.11.04. PMID: 29307196. NO IF.

32 Grothey A, Sobrero AF, Shields AF, Yoshino T, Paul J, Taieb J, Souglakos J, Shi Q, Kerr R, Labianca R, Meyerhardt JA, Vernerey D, Yamanaka T, Boukovinas I, Meyers JP, Renfro LA, Niedzwiecki D, Watanabe T, Torri V, Saunders M, Sargent DJ, Andre T, Iveson T. Duration of Adjuvant Chemotherapy for Stage III Colon Cancer. N Engl J Med. 2018 Mar 29;378(13):1177-1188. doi: 10.1056/NEJMoa1713709. PMID: 29590544. IF: 79.258. MEDICINE, GENERAL & INTERNAL, Q1.

33 Hervouet E. The Promising Role of New Generation HDACis in Anti-Cancer Therapies. EBioMedicine. 2018 Jun;32:6-7. doi: 10.1016/j.ebiom.2018.05.014. PMID: 29754883. IF: 6.183. MEDICINE, RESEARCH & EXPERIMENTAL, Q1.

34 Hervouet E, Peixoto P, Delage-Mourroux R, Boyer-Guittaut M, Cartron PF. Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma. Clin Epigenetics. 2018 Feb 9;10:17. doi: 10.1186/s13148-018-0450-y. PMID: 29449903. IF: 6.091. ONCOLOGY, Q1.

35 Isambert N, Hervieu A, Rébé C, Hennequin A, Borg C, Zanetta S, Chevriaux A, Richard C, Derangère V, Limagne E, Blanc J, Bertaut A, Ghiringhelli F. Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study. Oncoimmunology. 2018 Aug 1;7(9):e1474319. doi: 10.1080/2162402X.2018.1474319. eCollection 2018. PMID: 30228942. IF: 5. 503. ONCOLOGY, Q1.

36 Jacquinot Q, Paget-Bailly S, Fumoleau P, Romieu G, Pierga JY, Espié M, Lortholary A, Nabholtz JM, Mercier CF, Pauporté I, Henriques J, Pivot X. Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumab. Breast. 2018 Oct;41:1-7. doi: 10.1016/j.breast.2018.06.001. Epub 2018 Jun 15. PMID: 29913374. IF: 2.951. ONCOLOGY, Q2.

37 Kim S, François E, André T, Samalin E, Jary M, El Hajbi F, Baba-Hamed N, Pernot S, Kaminsky MC, Bouché O, Desrame J, Zoubir M, Ghiringhelli F, Parzy A, De La Fouchardiere C, Smith D, Deberne M, Spehner L, Badet N, Adotevi O, Anota A, Meurisse A, Vernerey D, Taieb J, Vendrely V, Buecher B, Borg C. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2018 Aug;19(8):1094-1106. doi: 10.1016/S1470-2045(18)30321-8. PMID: 30042063. IF: 36.421. ONCOLOGY, Q1.

38 Kroemer M, Spehner L, Mercier-Letondal P, Boullerot L, Kim S, Jary M, Galaine J, Picard E, Ferrand C, Nguyen T, Larosa F, Adotévi O, Godet Y, Borg C. SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts. Oncoimmunology. 2018 Jan 17;7(4):e1412030. doi: 10.1080/2162402X.2017.1412030. PMID: 29632725. IF: 5.503. ONCOLOGY, Q1. IMMUNOLOGY, Q1.

39 Kumar A, Tripathy MK, Pasquereau S, Al Moussawi F, Abbas W, Coquard L, Khan KA, Russo L, Algros MP, Valmary-Degano S, Adotevi O, Morot-Bizot S, Herbein G. The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells. EBioMedicine. 2018 Apr;30:167-183. doi: 10.1016/j.ebiom.2018.03.015. PMID: 29628341. IF: 6.183. MEDICINE, RESEARCH & EXPERIMENTAL, Q1.

40 Lamy T, Damaj G, Soubeyran P, Gyan E, Cartron G, Bouabdallah K, Gressin R, Cornillon J, Banos A, Le Du K, Benchalal M, Moles MP, Le Gouill S, Fleury J, Godmer P, Maisonneuve H, Deconinck E, Houot R, Laribi K, Marolleau JP, Tournilhac O, Branger B, Devillers A, Vuillez JP, Fest T, Colombat P, Costes V, Szablewski V, Béné MC, Delwail V; LYSA Group. R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma. Blood. 2018 Jan 11;131(2):174-181. doi: 10.1182/blood-2017-07-793984. PMID: 29061568. IF: 15.132. HEMATOLOGY, Q1.

41 Loubière S, Drezet A, Beau-Faller M, Moro-Sibilot D, Friard S, Wislez M, Blons H, Daniel C, Westeel V, Madroszyk A, Léna H, Merle P, Mazières J, Zalcman G, Lacave R, Antoine M, Morin F, Missy P, Barlesi F, Auquier P, Cadranel J; French Cooperative Thoracic Intergroup (IFCT). Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study. Eur Respir J. 2018 Mar 15;51(3). pii: 1701467. doi: 10.1183/13993003.01467-2017. PMID: 29545318. IF: 12.242. RESPIRATORY SYSTEM, Q1.

42 Magne J, Jenvrin A, Chauchet A, Casasnovas O, Donzel A, Jego L, Aral B, Guy J, Nadal N, Vernerey D, Callier P, Garnache-Ottou F, Ferrand C. Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies. Exp Hematol Oncol. 2018 Feb 20;7:5. doi: 10.1186/s40164-018-0097-6. PMID: 29484276. NO IF.

43 Mercier-Letondal P, Marton C, Deschamps M, Ferrand C, Vauchy C, Chenut C, Baguet A, Adotévi O, Borg C, Galaine J, Godet Y. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy. Hum Gene Ther. 2018 Oct;29(10):1202-1212. doi: 10.1089/hum.2018.091. PMID: 30136612. IF: 4.241. MEDICINE RESEARCH, EXPERIMENTAL SCIENCES, Q1.

44 Merveilleux du Vignaux C, Dansin E, Mhanna L, Greillier L, Pichon E, Kerjouan M, Clement-Duchene C, Mennecier B, Westeel V, Robert M, Quantin X, Zalcman G, Thiberville L, Lena H, Molina T, Calcagno F, Fournel P, Mazieres J, Besse B, Girard N. Systemic therapy in advanced thymic epithelial tumors: Insights from the RYTHMIC prospective cohort. J Thorac Oncol. 2018 Aug 20. pii: S1556-0864(18)30943-2. doi: 10.1016/j.jtho.2018.08.005. [Epub ahead of print]. PMID: 30138763. IF: 10.340. ONCOLOGY, Q1.

45 Meyer G, Besse B, Doubre H, Charles-Nelson A, Aquilanti S, Izadifar A, Azarian R, Monnet I, Lamour C, Descourt R, Oliviero G, Taillade L, Chouaid C, Giraud F, Falcoz PE, Revel MP, Westeel V, Dixmier A, Tredaniel J, Dehette S, Decroisette C, Prevost A, Pichon E, Fabre E, Soria JC, Friard S, Stern JB, Jabot L, Dennewald G, Pavy G, Petitpretz P, Tourani JM, Alifano M, Chatellier G, Girard P. Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial. Eur Respir J. 2018 Oct 4;52(4). pii: 1801220. doi: 10.1183/13993003.01220-2018. PMID: 30262574. IF: 12.242. RESPIRATORY SYSTEM, Q1.

46 Mouillet G, Paillard MJ, Maurina T, Vernerey D, Nguyen Tan Hon T, Almotlak H, Stein U, Calcagno F, Berthod D, Robert E, Meurisse A, Thiery-Vuillemin A. Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial. Trials. 2018 Apr 12;19(1):221. doi: 10.1186/s13063-018-2613-8. PMID: 29650037. IF: 2.067. MEDICINE, RESEARCH & EXPERIMENTAL, Q3.

47 Ousmen A, Touraine C, Deliu N, Cottone F, Bonnetain F, Efficace F, Brédart A, Mollevi C, Anota A. Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review. Health Qual Life Outcomes. 2018 Dec 11;16(1):228. doi: 10.1186/s12955-018-1055-z. PMID: 30537955. IF: 2.278, HEALTH POLICIES & SERVICES, Q2.

48 Peffault de Latour R, Tabrizi R, Marcais A, Leblanc T, Lamy T, Mohty M, Tavitian S, Jubert C, Pasquet M, Galambrun C, Nguyen S, Cahn JY, Braun T, Deconinck E, Bay JO, Sicre de Fontbrune F, Barraco F, Socié G. Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia. Am J Hematol. 2018 May;93(5):635-642. doi: 10.1002/ajh.25050. PMID: 29377260. IF: 5.303. HEMATOLOGY, Q1.

49 Picard E, Godet Y, Laheurte C, Dosset M, Galaine J, Beziaud L, Loyon R, Boullerot L, Lauret Marie Joseph E, Spehner L, Jacquin M, Eberst G, Gaugler B, Le Pimpec-Barthes F, Fabre E, Westeel V, Caignard A, Borg C, Adotévi O. Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer. Oncoimmunology. 2018 Oct 19;8(2):e1527498. doi: 10.1080/2162402X.2018.1527498. PMID: 30713781 IF: 5.503. ONCOLOGY, Q1. IMMUNOLOGY, Q1.

50 Pivot X, Bondarenko I, Nowecki Z, Dvorkin M, Trishkina E, Ahn JH, Vinnyk Y, Im SA, Sarosiek T, Chatterjee S, Wojtukiewicz MZ, Moiseyenko V, Shparyk Y, Bello M 3rd, Semiglazov V, Song S, Lim J. Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer. J Clin Oncol. 2018 Apr 1;36(10):968-974. doi: 10.1200/JCO.2017.74.0126. PMID: 29373094. IF: 26.303. ONCOLOGY, Q1.

51 Pivot X, Bondarenko I, Petit T, Curtit E. Milestones over the development of SB3, a trastuzumab biosimilar. Future Oncol. 2018 Jun 21. doi: 10.2217/fon-2018-0270. [Epub ahead of print]. PMID: 29927335. IF: 2.369. ONCOLOGY, Q3.

52 Pivot X, Cox DG, Gligorov J. Why the results of adjuvant pertuzumab in HER2-positive early breast cancer has been received as a mitigate success? Chin Clin Oncol. 2018 Feb;7(1):1. doi: 10.21037/cco.2017.10.07. PMID: 29156890. NO IF.

53 Pourcelot C, Orillard E, Nallet G, Dirand C, Billion-Rey F, Barbier G, Chouk S, Limat S, Montcuquet P, Henriques J, Paget-Bailly S, Anota A, Chaigneau L, Nerich V. Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence. Breast Cancer Res Treat. 2018 May;169(1):153-162. doi: 10.1007/s10549-018-4676-3. Epub 2018 Jan 23. PMID: 29362956. IF: 3.605. ONCOLOGY, Q2.

54 Quoix E, Westeel V. Time to give a rest to cetuximab in the treatment of advanced non-small cell lung carcinoma? J Thorac Dis. 2018 Sep;10(Suppl 26):S3043-S3046. doi: 10.21037/jtd.2018.08.33. No PMID: 30370073. IF: 1.804, RESPIRATORY SYSTEM, Q4.

55 Salvatore D, Labopin M, Ruggeri A, Battipaglia G, Ghavamzadeh A, Ciceri F, Blaise D, Arcese W, Socié G, Bourhis JH, Van Lint M, Bruno B, Huynh A, Santarone S, Deconinck E, Mohty M, Nagler A. Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica. 2018 Aug;103(8):1317-1328. doi: 10.3324/haematol.2018.189258. PMID: 29748438. IF: 9.090. HEMATOLOGY, Q1.

56 Scherpereel A, Durand-Zaleski I, Cotté FE, Fernandes J, Debieuvre D, Blein C, Gaudin AF, Tournier C, Vainchtock A, Chauvin P, Souquet PJ, Westeel V, Chouaïd C. Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study. BMC Cancer. 2018 Oct 22;18(1):1013. doi: 10.1186/s12885-018-4958-5. PMID: 30348130. IF: 3.288. ONCOLOGY, Q2.

57 Schillinger F, Sourdeau E, Boubaya M, Baseggio L, Clauser S, Cornet E, Debord C, Defour JP, Dubois F, Eveillard M, Galoisy AC, Geay MO, Mullier F, Nivaggioni V, Soenen V, Morel P, Garnache-Ottou F, Ronez E, Bardet V, Deconinck E. A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XNTM analyzers in routine laboratory practice. Scand J Clin Lab Invest. 2018 May;78(3):159-164. doi: 10.1080/00365513.2018.1423702. PMID: 29310473. IF: 1.498. MEDICINE, RESEARCH & EXPERIMENTAL, Q4.

58 Schwarz L, Vernerey D, Bachet JB, Tuech JJ, Portales F, Michel P, Cunha AS. Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy – a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study). BMC Cancer. 2018 Jul 24;18(1):762. doi: 10.1186/s12885-018-4663-4. PMID: 30041614. IF: 3.288. ONCOLOGY, Q2.

59 Seigeot A, Desmarets M, Rumpler A, Leroux F, Deconinck E, Monnet E, Bardiaux L. Factors related to the outcome of prophylactic platelet transfusions in patients with hematologic malignancies: an observational study. Transfusion. 2018 Mar 14. doi: 10.1111/trf.14592. [Epub ahead of print]. PMID: 29542122. IF: 3.423. HEMATOLOGY, Q2.

60 Shimoni A, Labopin M, Savani B, Hamladji RM, Beelen D, Mufti G, Socié G, Delage J, Blaise D, Chevallier P, Forcade E, Deconinck E, Mohty M, Nagler A. Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2018 Apr;24(4):751-757. doi: 10.1016/j.bbmt.2017.12.776. PMID: 29247780. IF: 4.484. HEMATOLOGY, Q2. IMMUNOLOGY, Q2. TRANSPLANTATION, Q1.

61 Thiery-Vuillemin A, Cholley T, Calcagno F, Hugues M, Maurina T, Limat S, Nguyen Tan Hon T, Almotlak H, Mouillet G, Nerich V. Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice. Clin Genitourin Cancer. 2018 Apr;16(2):e297-e305. doi: 10.1016/j.clgc.2017.09.006. Epub 2017 Sep 25. PMID: 29066073. IF: 2.539. ONCOLOGY, Q3.

62 Tozatto-Maio K, Giannotti F, Labopin M, Ruggeri A, Volt F, Paviglianiti A, Kenzey C, Hayashi H, Cornelissen J, Michallet M, Karakasis D, Deconinck E, Rohrlich PS, de la Tour RP, Blaise D, Petersen E, D’Aveni M, Sengeloev H, Lamy T, Russell NH, Forcade E, Craddock CF, Nagler A, Gluckman E, Rocha V. Cord Blood Unit Dominance Analysis and Effect of the Winning Unit on Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee of Cellular Therapy, Immunobiology Working Party, and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2018 Aug;24(8):1657-1663. doi: 10.1016/j.bbmt.2018.02.014. PMID: 29477777. IF: 4.484. HEMATOLOGY, Q2. IMMUNOLOGY, Q2. TRANSPLANTATION, Q1.

63 Verine J, Colin D, Nheb M, Prapotnich D, Ploussard G, Cathelineau X, Desgrandchamps F, Mongiat-Artus P, Feugeas JP. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems. Am J Surg Pathol. 2018 Apr;42(4):423-441. doi: 10.1097/PAS.0000000000001025. PMID: 29356723. IF: 5.878. PATHOLOGY, Q1. SURGERY, Q1.

64 Vrecko S, Guenat D, Mercier-Letondal P, Faucheu H, Dosset M, Royer B, Galaine J, Boidot R, Kim S, Jary M, Adotévi O, Borg C, Godet Y. Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment. Oncotarget. 2018 Oct 23;9(83):35394-35407. doi: 10.18632/oncotarget.26247. PMID: 30459932. IF : suspendu.